10th Edition of World Congress on Infectious Diseases
June 25-27, 2026 | Barcelona, Spain
Rubella
Rubella, also known as German measles, is a viral infection caused by the rubella virus. The virus primarily spreads through respiratory droplets and is characterized by a mild rash, fever, and lymphadenopathy. While rubella infection is generally mild, its significant impact lies in its potential to cause congenital rubella syndrome (CRS) if contracted by pregnant women, especially during the first trimester. Congenital rubella syndrome is associated with severe birth defects, including deafness, cataracts, heart defects, and intellectual disabilities. The devastating consequences of CRS highlight the importance of preventing rubella in pregnant women through vaccination. The widespread use of the rubella vaccine as part of the measles, mumps, and rubella (MMR) vaccine has led to a significant decline in rubella cases and CRS globally.
Francis J Castellino
University of Notre Dame, United States
Ranjan Ramasamy
ID-FISH Technology, United States
Yazdan Mirzanejad
University of British Columbia, Canada
Alexis Torres Rodriguez
NewYork-Presbyterian Queens Hospital, United States
Sasha Leibholz
New York Presbyterian Columbia/Cornell, United States
Hana Raza
Mclaren Oakland Hospital, United States
Terri Menser
Mayo Clinic, United StatesSubmit your abstract Today
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation